For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7% on average.

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.

Children living in states with permissive firearm policies have thousands of excess firearm deaths versus children living in states with strict firearm policies.